)
Inogen (INGN) investor relations material
Inogen Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting scheduled for June 5, 2026, will be held virtually, allowing shareholders to vote and submit questions online.
Recent operational and strategic turnaround initiatives led to a return to positive Adjusted EBITDA in 2025.
Leadership strengthened with a new independent director and key senior management hires aligned with strategic priorities.
Share repurchase program approved and proposal to declassify the Board recommended, reflecting commitment to shareholder value and governance.
Active engagement with shareholders, including expanded outreach and a cooperation agreement with key investors.
Voting matters and shareholder proposals
Proposals include electing two Class III directors, ratifying Deloitte & Touche LLP as auditor, advisory approval of executive compensation, approval of the Amended and Restated 2023 Equity Incentive Plan, and declassification of the Board.
Board recommends voting FOR all proposals.
Shareholders of record as of April 6, 2026, are entitled to vote.
Cooperation Agreement with certain investors includes voting in line with Board recommendations and standstill provisions.
Board of directors and corporate governance
Board consists of seven members, six of whom are independent; a new director, Vafa Jamali, will join as of the Annual Meeting.
Board leadership structure requires separation of Chairperson and CEO roles, with an independent Chairperson.
Board diversity metrics disclosed; four of eight directors are female, and three self-identify as minorities or underrepresented.
Four standing committees: Audit, Compensation, Compliance, and Nominating and Governance, all meeting independence requirements.
Board and committee meetings held regularly, with high attendance and regular executive sessions for independent directors.
- Shareholders will vote on board declassification, equity plan expansion, and key governance changes.INGN
Proxy filing17 Apr 2026 - New products and leadership drive growth, margin expansion, and strategic transformation.INGN
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - Diversifying into respiratory care, achieving financial turnaround, and launching innovative products.INGN
Company presentation20 Mar 2026 - Diversified portfolio and innovation pipeline set to drive growth and profitability.INGN
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - 2025 revenue rose 3.9–4% with improved profitability and a $30M buyback; 2026 targets 6% growth.INGN
Q4 202524 Feb 2026 - Q2 revenue up 6.1% to $88.8M, gross margin 48.1%, net loss narrowed, B2B led growth.INGN
Q2 20242 Feb 2026 - Q3 revenue up 5.8%, net loss narrows, gross margin rises, and adjusted EBITDA turns positive.INGN
Q3 202415 Jan 2026 - Leadership overhaul and channel optimization set the stage for profitable growth and innovation.INGN
Stifel 2024 Healthcare Conference13 Jan 2026 - Portfolio expansion and operational improvements position for growth in the under-penetrated respiratory market.INGN
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026
Next Inogen earnings date
Next Inogen earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)